Concepedia

LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801

Sapna P. Patel, Megan Othus, Paul Wright, John Hyngstrom, Christopher D. Lao, T-G. Truong, Sunandana Chandra, Kari Kendra, Craig Devoe, Aparna Hegde,

Annals of Oncology · 2023 · 17 citations · 0 references

DOI

Concepts